Terveystalo Oy Class A

Terveystalo Oy Class A's next confirmed earnings release is scheduled for February 12, 2027.

As of June 30, 2026, Terveystalo Oy Class A has 126.81M shares outstanding.

As of June 30, 2026, Terveystalo Oy Class A maintains a current ratio of 0.61, meaning it holds 0.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 121.74, indicating elevated leverage, while an interest coverage ratio of 10.39 demonstrates strong ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Terveystalo Oy Class A posted a return on equity (ROE) of 13.26, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 7.83 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 5.19, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 7.77, useful for judging operating efficiency across full business cycles. The company generates approximately 146,459.78 in revenue per employee across its workforce of 8,555.25, a quick read on workforce productivity versus industry peers. Inventory turnover of 64.94 indicates how many times Terveystalo Oy Class A sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Terveystalo Oy Class A recorded 19.50M in income tax expense. That works out to an effective tax rate of 20.86, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 93.50M, leaving 74.00M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

Over the twelve months ended June 30, 2026, Terveystalo Oy Class A generated 1.25B in revenue and converted that into 74.00M in net income, yielding earnings per share of 0.58. EBITDA reached 216.20M, while operating income came in at 115.60M.

As of June 30, 2026, Terveystalo Oy Class A holds 87.50M in cash and equivalents against 647.40M in total debt, resulting in a net debt position of 366.50M. Total book value stands at 531.80M, with working capital of -142.60M providing operational flexibility.

Terveystalo Oy Class A produced 160.90M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -55.10M in capital expenditures, free cash flow totaled 105.80M - equivalent to 0.84 per share.

Over the twelve months ended June 30, 2026, Terveystalo Oy Class A posted a gross margin of 59.83, reflecting its pricing power and cost economics. The operating margin of 9.23 and net profit margin of 5.91 provide insight into operational efficiency.

Over the twelve months ended June 30, 2026, Terveystalo Oy Class A paid dividends of 0.80 per share. The dividend payout ratio of 137.03 exceeds 100%, meaning the company is distributing more than it earns and funding the dividend from cash reserves, asset sales, or borrowing, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth.